惠伦晶体(300460) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the period was ¥102,158,619.73, representing a 6.73% increase year-on-year[8] - Net profit attributable to shareholders rose by 116.17% to ¥6,148,616.05 for the quarter[8] - The net profit after deducting non-recurring gains and losses surged by 219.89% to ¥5,447,048.46[8] - Basic earnings per share increased by 77.51% to ¥0.0300[8] - Diluted earnings per share rose by 54.44% to ¥0.0261[8] - The company's net increase in cash and cash equivalents rose by 51.33% compared to the same period last year, mainly due to increased net cash inflows from operating and financing activities[17] - The company reported a significant increase in operating income from non-recurring government subsidies, which rose by 1,461.71% compared to the same period last year[16] - The net profit for the third quarter was CNY 6,148,616.05, up from CNY 2,844,342.07 in the same period last year, representing a significant increase[37] - The net profit for the current period was ¥5,710,480.84, compared to ¥3,605,508.52 in the previous period, reflecting a growth of approximately 58.3%[41] - The total comprehensive income for the current period was ¥6,148,616.05, up from ¥2,844,342.07 in the previous period[41] - The company reported a significant increase in operating profit to ¥5,739,646.30 from ¥3,604,276.35, marking a growth of approximately 59.2%[41] - The company’s total comprehensive income attributable to the parent company was ¥10,421,998.62, up from ¥3,124,236.10 in the previous period, reflecting a growth of approximately 233.5%[46] - The net profit for the period was ¥10,060,317.31, significantly up from ¥198,199.74, marking a growth of 4,973.5% year-over-year[50] Assets and Liabilities - Total assets increased by 26.09% to ¥1,016,214,080.12 compared to the end of the previous year[8] - The total assets as of September 30, 2020, were CNY 1,010,740,259.57, compared to CNY 817,296,537.07 at the end of 2019[32] - The total liabilities increased to CNY 479,397,428.86 from CNY 296,014,023.67 year-over-year[33] - The company's total liabilities included short-term borrowings of ¥36,304,235.87 and accounts payable of ¥65,212,726.97[61] - Owner's equity totaled CNY 521,282,513.40, including CNY 168,274,200.00 in share capital and CNY 68,350,370.30 in undistributed profits[66] - The company reported a total asset value of ¥805,957,053.72, with total liabilities at ¥282,569,853.28 and total equity at ¥523,387,200.44[62] Cash Flow - Net cash flow from operating activities increased by 437.84% to ¥23,884,178.11[8] - Cash flow from operating activities generated a net amount of ¥33,549,534.17, up from ¥23,804,389.03, indicating a growth of 40.9%[53] - The total cash inflow from financing activities was ¥241,900,000.00, a significant increase from ¥41,757,407.23 in the previous year[54] - The company reported a net cash outflow from investing activities of ¥214,477,808.76, compared to a net outflow of ¥23,263,718.89 last year, indicating increased investment activities[54] - The cash and cash equivalents at the end of the period were ¥26,693,244.44, down from ¥28,122,248.52, indicating a decrease in liquidity[54] - The total cash and cash equivalents at the end of the period was ¥11,158,019.07, down from ¥30,206,026.15 at the beginning of the period[57] Inventory and Receivables - Trade receivables increased by 332.99% compared to the beginning of the year, primarily due to an increase in bank acceptance bills received from customers[16] - Inventory increased by 35.59% compared to the beginning of the year, as the company increased reserves of key raw materials based on future market forecasts[16] - The company reported inventory of CNY 135,601,173.15 and other receivables of CNY 17,923,977.11[64] Research and Development - The company’s research and development expenses were CNY 2,441,688.81, slightly down from CNY 2,517,109.86 in the previous period[36] - Research and development expenses for the current period were ¥1,467,750.70, slightly down from ¥1,483,914.62 in the previous period[40] - The company reported an increase in research and development expenses to ¥7,530,633.13 from ¥6,743,293.66, highlighting a commitment to innovation[48] Other Financial Metrics - The weighted average return on equity was 1.16%, up from 0.73% in the previous year[8] - The company received government subsidies amounting to ¥2,781,076.22 during the reporting period[9] - The total operating costs amounted to CNY 97,297,447.34, compared to CNY 94,205,993.46 in the prior period[36] - The company's total operating costs were ¥79,671,783.18, compared to ¥70,174,279.02 in the previous period, indicating an increase of approximately 13.5%[40] - The total amount of other payables was CNY 33,536,419.89, which is a key component of current liabilities[65] Changes in Financial Reporting - The company has adjusted its financial statements in accordance with new revenue and leasing standards effective from 2020[58] - The report reflects the first implementation of new revenue and leasing standards starting in 2020, with no retrospective adjustments made[66]